mutation, alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.
作者信息
Hof Jana, Kox Corinne, Groeneveld-Krentz Stefanie, Bandapalli Obul R, Karawajew Leonid, Schedel Katharina, Kunz Joachim B, Eckert Cornelia, Ludwig Wolf-Dieter, Ratei Richard, Rhein Peter, Henze Günter, Muckenthaler Martina U, Kulozik Andreas E, von Stackelberg Arend, Kirschner-Schwabe Renate
机构信息
Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany.
出版信息
Haematologica. 2017 Jul;102(7):e249-e252. doi: 10.3324/haematol.2016.157792. Epub 2017 Mar 30.
Abstract
摘要
相似文献
1
mutation, alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.突变、改变和髓系抗原表达可预测T细胞急性淋巴细胞白血病首次复发儿童的预后异质性。
Haematologica. 2017 Jul;102(7):e249-e252. doi: 10.3324/haematol.2016.157792. Epub 2017 Mar 30.
2
Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.作为一种显性负性可变剪接模型，c-myc转录抑制因子FIR的单倍剂量不足通过激活Notch1促进了p53依赖性T细胞急性淋巴细胞白血病的进展。
Oncotarget. 2015 Mar 10;6(7):5102-17. doi: 10.18632/oncotarget.3244.
3
Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.基于 NOTCH1/FBXW7/RAS/PTEN 的成人生髓系急性淋巴细胞白血病的癌基因风险分类：一个成人急性淋巴细胞白血病研究小组的研究。
J Clin Oncol. 2013 Dec 1;31(34):4333-42. doi: 10.1200/JCO.2012.48.5292. Epub 2013 Oct 28.
4
NOTCH mutations as prognostic markers in T-ALL.NOTCH突变作为T细胞急性淋巴细胞白血病的预后标志物。
Leukemia. 2010 Dec;24(12):2003-4. doi: 10.1038/leu.2010.237.
5
NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.NOTCH1 激活在 BFM 治疗的前体 T 细胞急性淋巴细胞白血病患儿中，临床上拮抗了 PTEN 失活的不利影响。
Haematologica. 2013 Jun;98(6):928-36. doi: 10.3324/haematol.2012.073585. Epub 2013 Jan 24.
6
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.RNA测序揭示难治性/复发性T细胞急性淋巴细胞白血病的遗传学。预后及治疗意义。
Haematologica. 2016 Aug;101(8):941-50. doi: 10.3324/haematol.2015.139410. Epub 2016 May 5.
7
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.RAS 和 TP53 可预测接受高强度 CVAD 治疗的成人 T 细胞淋巴母细胞白血病患者的生存情况。
Cancer Med. 2020 Feb;9(3):849-858. doi: 10.1002/cam4.2757. Epub 2019 Dec 5.
8
FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.儿童T细胞急性淋巴细胞白血病和T细胞非霍奇金淋巴瘤中的FBXW7和NOTCH1突变
Br J Haematol. 2009 Apr;145(2):198-206. doi: 10.1111/j.1365-2141.2009.07607.x. Epub 2009 Feb 24.
9
Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.突变型 p53 通过 Notch1 拮抗 p63/p73 介导的肿瘤抑制作用。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24259-24267. doi: 10.1073/pnas.1913919116. Epub 2019 Nov 11.
10
Prognostic impact of the absence of biallelic deletion at the locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial.在英国医学研究理事会2003年急性淋巴细胞白血病试验中接受治疗的T细胞急性淋巴细胞白血病儿科患者中，该基因座双等位基因缺失的缺失对预后的影响。
Haematologica. 2018 Jul;103(7):e288-e292. doi: 10.3324/haematol.2017.185801. Epub 2018 Mar 8.
引用本文的文献
1
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控：对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
2
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.将WEE1激酶作为高危和复发急性淋巴细胞白血病中一种不依赖p53的治疗策略。
Cancer Cell Int. 2023 Sep 15;23(1):202. doi: 10.1186/s12935-023-03057-8.
3
Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse.化疗与错配修复缺陷协同作用促进 TP53 突变和 ALL 复发。
Nat Cancer. 2021 Aug;2(8):819-834. doi: 10.1038/s43018-021-00230-8. Epub 2021 Jul 22.
4
[The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].NOTCH1在T细胞急性淋巴细胞白血病中的作用及研究进展
Zhonghua Xue Ye Xue Za Zhi. 2021 Feb 14;42(2):165-170. doi: 10.3760/cma.j.issn.0253-2727.2021.02.014.
5
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.儿童急性淋巴细胞白血病在异基因造血干细胞移植后复发具有高度的个体性、克隆动力学、选择压力和可治疗靶点。
Blood Adv. 2019 Oct 22;3(20):3143-3156. doi: 10.1182/bloodadvances.2019000051.
本文引用的文献
1
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.RNA测序揭示难治性/复发性T细胞急性淋巴细胞白血病的遗传学。预后及治疗意义。
Haematologica. 2016 Aug;101(8):941-50. doi: 10.3324/haematol.2015.139410. Epub 2016 May 5.
2
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.采用AIEOP - BFM方案在AIEOP中心治疗的儿童早期T细胞前体急性淋巴细胞白血病：一项回顾性分析
Lancet Haematol. 2016 Feb;3(2):e80-6. doi: 10.1016/S2352-3026(15)00254-9. Epub 2016 Jan 26.
3
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.青少年及成人早期T细胞前体急性淋巴细胞白血病/淋巴瘤（ETP-ALL/LBL）：一种高危亚型
Blood. 2016 Apr 14;127(15):1863-9. doi: 10.1182/blood-2015-08-661702. Epub 2016 Jan 8.
4
Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.PTEN异常对在英国医学研究委员会UKALL2003试验中接受治疗的儿童T细胞急性淋巴细胞白血病患者预后的影响。
Leukemia. 2016 Jan;30(1):39-47. doi: 10.1038/leu.2015.206. Epub 2015 Jul 29.
5
Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.基于 NOTCH1/FBXW7/RAS/PTEN 的成人生髓系急性淋巴细胞白血病的癌基因风险分类：一个成人急性淋巴细胞白血病研究小组的研究。
J Clin Oncol. 2013 Dec 1;31(34):4333-42. doi: 10.1200/JCO.2012.48.5292. Epub 2013 Oct 28.
6
Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.根据欧洲白血病免疫学分型协作组（EGIL）建议对儿童急性淋巴细胞白血病进行谱系分类：ALL-BFM 2000试验结果
Klin Padiatr. 2013 May;225 Suppl 1:S34-9. doi: 10.1055/s-0033-1337961. Epub 2013 May 22.
7
NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.NOTCH1 激活在 BFM 治疗的前体 T 细胞急性淋巴细胞白血病患儿中，临床上拮抗了 PTEN 失活的不利影响。
Haematologica. 2013 Jun;98(6):928-36. doi: 10.3324/haematol.2012.073585. Epub 2013 Jan 24.
8
How I treat relapsed childhood acute lymphoblastic leukemia.我如何治疗复发的儿童急性淋巴细胞白血病。
Blood. 2012 Oct 4;120(14):2807-16. doi: 10.1182/blood-2012-02-265884. Epub 2012 Aug 15.
9
Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.NOTCH1/FBXW7 突变对 MRC UKALL 2003 试验治疗的儿童 T 细胞急性淋巴细胞白血病患者结局的影响。
Leukemia. 2013 Jan;27(1):41-7. doi: 10.1038/leu.2012.176. Epub 2012 Jul 3.
10
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.TP53 基因突变和缺失可预测儿童急性淋巴细胞白血病首次复发时治疗无反应和预后不良。
J Clin Oncol. 2011 Aug 10;29(23):3185-93. doi: 10.1200/JCO.2011.34.8144. Epub 2011 Jul 11.
Zotero 插件